| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.370 | AlteredExpression | disease | BEFREE | Therefore, the aim of this study was to assess the profile of CD39, CD43, CD81, and CD95 expressions in diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), and Burkitt lymphoma (BL) cases. | 28509416 | 2018 | ||||
|
0.370 | Biomarker | disease | CTD_human | Genomic landscape of cutaneous T cell lymphoma. | 26192916 | 2015 | ||||
|
0.370 | Biomarker | disease | BEFREE | Deletions at 13q14.3 might contribute to DLBCL pathogenesis by two mechanisms: deregulating the cell cycle control mainly due RB1 loss and contributing to immune escape, due to FAS down-regulation. | 21693768 | 2012 | ||||
|
0.370 | AlteredExpression | disease | BEFREE | In conclusion, positive CD95 expression proved to be a good prognostic factor of overall survival in both extranodal DLBCLs and MALTLs. | 20352431 | 2010 | ||||
|
0.370 | GeneticVariation | disease | BEFREE | No CD95 mutations in the two analyzed regions were detected in primary extranodal DLBCL, mediastinal large B-cell lymphoma (MLBCL), and DLBCL arising from indolent low-grade lymphomas. | 17487740 | 2007 | ||||
|
0.370 | AlteredExpression | disease | BEFREE | FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes. | 16740746 | 2006 | ||||
|
0.370 | GeneticVariation | disease | BEFREE | Since primary gastric lymphomas frequently exhibit resistance to FAS-mediated apoptosis, we investigated whether FAS is mutated in 18 gastric MALT lymphomas and 28 diffuse large B-cell lymphomas (DLBCL). | 14982861 | 2004 | ||||
|
0.370 | GeneticVariation | disease | BEFREE | Indeed, mutations of the FAS antigen have been found in 13% of multiple myelomas, 6% of follicle center lymphomas (FCL) and 21% of diffuse large B-cell lymphomas (DLBCL). | 12952224 | 2003 |